TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 44 filers reported holding TALIS BIOMEDICAL CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $43,902 | +54777.5% | 91,463 | -44.1% | 0.00% | – |
Q1 2023 | $80 | +63.3% | 163,663 | +47.4% | 0.00% | – |
Q4 2022 | $49 | -99.9% | 111,036 | -14.2% | 0.00% | – |
Q3 2022 | $88,000 | -46.3% | 129,372 | -35.9% | 0.00% | – |
Q2 2022 | $164,000 | +4.5% | 201,913 | +1320.0% | 0.00% | – |
Q2 2021 | $157,000 | – | 14,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 2,235,783 | $1,073,176 | 0.05% |
WELLS FARGO & COMPANY/MN | 174 | $84 | 0.00% |
NORTHERN TRUST CORP | 27,860 | $13,373 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 140,530 | $67,454 | 0.00% |
STATE STREET CORP | 47,436 | $22,769 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 91,463 | $43,902 | 0.00% |
DEUTSCHE BANK AG\ | 45,294 | $21,741 | 0.00% |
MORGAN STANLEY | 61,857 | $29,691 | 0.00% |
BlackRock Inc. | 76,307 | $36,628 | 0.00% |